Factors influencing the outcome of balloon aortic valvuloplasty in the elderly
| Autor: | Steven T. Minor, David A. Samuels, M. Stewart West, Clement A. DeFelice, Neal S. Kleiman, J.Dwayne Pickett, John M. Lewis, Richard W. Cashion, William A. Zoghbi, Arsenio R. Rodriguez, Albert E. Raizner |
|---|---|
| Rok vydání: | 1990 |
| Předmět: |
Aortic valve
Reoperation medicine.medical_specialty medicine.medical_treatment Balloon Asymptomatic Catheterization Aortic valve replacement Recurrence Internal medicine medicine Humans Aged Ejection fraction business.industry Hemodynamics Aortic Valve Stenosis medicine.disease Prognosis Survival Analysis Aortic valvuloplasty Surgery Hospitalization Stenosis medicine.anatomical_structure Heart failure Heart Valve Prosthesis cardiovascular system Cardiology medicine.symptom Cardiology and Cardiovascular Medicine business |
| Zdroj: | American heart journal. 120(2) |
| ISSN: | 0002-8703 |
| Popis: | This study describes the short- and long-term outcome of 44 consecutive percutaneous balloon aortic valvuloplasty procedures performed in 42 elderly patients (age 77.8 ± 7 years) with calcific aortic stenosis. The initial success rate was 95%, with the peak aortic valve pressure gradient declining from a mean of 82 ± 32 mm Hg to 44 ± 23 mm Hg and aortic valve area increasing from a mean of 0.59 ± 0.15 cm2 to 0.83 ± 0.40 cm2. One procedure-related death occurred and an additional three patients died ≤30 days after balloon aortic valvuloplasty. These patients all had New York Heart Association (NYHA) class IV heart failure symptoms prior to the procedure and their mean left ventricular ejection fraction (LVEF) (28 ± 7%) was lower than that of hospital survivors (52 ± 13%) (as was their ratio of left ventricular [LV] wall thickness-to-cavity ratio [0.50 ± 0.10 versus 0.70 ± 0.15]). At the time of hospital discharge after valvuloplasty, 76% of patients were asymptomatic or markedly improved (NYHA class I or II). After a mean follow-up of 15.5 months (range 2 to 26 months), however, 10 patients had died and 15 had undergone aortic valve replacement for recurrence of NYHA class III or IV symptoms. The adjusted 1- and 2-year survivals were 0.68 and 0.62, respectively, and adjusted 2-year event-free survival was 0.25. Proportional hazard regression analysis indicated that LVEF |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|